The relationship between small-intestinal bacterial overgrowth and intestinal permeability in patients with irritable bowel syndrome

Gut and Liver

Volumn 3, Issue 3, 2009, Pages 174-179

  Jung, Ho Park ^a   Dong, Il Park ^a   Hong, Joo Kim ^a   Yong, Kyun Cho ^a   Chong, Il Sohn ^a   Woo, Kyu Jeon ^a   Byung, Ik Kim ^a   Kyoung, Hee Won ^a   Soon, Min Park ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Intestinal permeability; Irritable bowel syndrome; Small intestinal bacterial overgrowth

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL OVERGROWTH; BREATH ANALYSIS; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIARRHEA; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOSTIMULATION; INTESTINE MUCOSA PERMEABILITY; IRRITABLE COLON; MALE; SMALL INTESTINE;

EID: 70349327608     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2009.3.3.174     Document Type: Article

References (34)

1. Lin HC. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA 2004;292:852-858. (Pubitemid 39079672)
2. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003;98:412-419. (Pubitemid 36232393)
3. Posserud I, Stotzer PO, Bjornsson ES, Abrahamsson H, Simren M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007;56:802-808. (Pubitemid 46854194)
4. Lupascu A, Gabrielli M, Lauritano EC, et al. Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther 2005;22:1157-1160. (Pubitemid 41779524)
5. Walters B, Vanner SJ. Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls. Am J Gastroenterol 2005;100:1566-1570. (Pubitemid 41032365)
6. Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000;95:3503-3506.
7. Hong KS, Kang HW, Im JP, et al. Effect of probiotics on symptoms in Korean adults with irritable bowel syndrome. Gut Liver 2009;3:101-107.
8. Berg RD, Garlington AW. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 1979;23:403-411.
9. Woodcock NP, Robertson J, Morgan DR, Gregg KL, Mitchell CJ, MacFie J. Bacterial translocation and immunohistochemical measurement of gut immune function. J Clin Pathol 2001;54:619-623. (Pubitemid 32756445)
10. Nieuwenhuijs VB, Verheem A, van Duijvenbode-Beumer H, et al. The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats. Ann Surg 1998;228:188-193. (Pubitemid 30191713)
11. Weston AP, Biddle WL, Bhatia PS, Miner PB Jr. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993;38:1590-1595.
12. O'Sullivan M, Clayton N, Breslin NP, et al. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000;12:449-457. (Pubitemid 30728569)
13. Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400-406. (Pubitemid 29119338)
14. Salzmann JL, Peltier-Koch F, Bloch F, Petite JP, Camilleri JP. Morphometric study of colonic biopsies: a new method of estimating inflammatory diseases. Lab Invest 1989;60:847-1551 (Pubitemid 19168995)
15. O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005;128:541-551. (Pubitemid 40585355)
16. Al-Khatib K, Lin HC. Immune activation and gut microbes in irritable bowel syndrome. Gut Liver 2009;3:14-19.
17. Forget P, Sodoyez-Goffaux F, Zappitelli A. Permeability of the small intestine to [51Cr]EDTA in children with acute gastroenteritis or eczema. J Pediatr Gastroenterol Nutr 1985;4:393-396. (Pubitemid 15064026)
18. Bjarnson I, O'Morain C, Levi AJ, Peters TJ. Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenterology 1983;85:318-322.
19. Dunlop SP, Hebden J, Campbell E, et al. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol 2006;101:1288-1294. (Pubitemid 43829995)
20. Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 2002;123:450-460. (Pubitemid 34827189)
21. Dainese R, Galliani EA, De Lazzari F, Di Leo V, Naccarato R. Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients. Am J Gastroenterol 1999;94:1892-1897. (Pubitemid 29315906)
22. American Gastroenterology Association. American Gastroenterological Association medical position statement: irritable bowel syndrome. Gastroenterology 2002;123:2105-2107. (Pubitemid 35408331)
23. Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology 2003;124:1662-1671.
24. Beck A, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
25. Spielberger C. Manual for the state-trait anxiety inventory. Palo Alto: Consulting Psychologists Press, 1983.
26. Peled Y, Weinberg D, Hallak A, Gilat T. Factors affecting methane production in humans: gastrointestinal diseases and alterations of colonic flora. Dig Dis Sci 1987;32:267-271. (Pubitemid 17054267)
27. DiPalma JA, Brady CE 3rd, Stewart DL, et al. Comparison of colon cleansing methods in preparation for colonoscopy. Gastroenterology 1984;86:856-860.
28. Schiller LR, Santa Ana CA, Porter J, Fordtran JS. Validation of polyethylene glycol 3350 as a poorly absorbable marker for intestinal perfusion studies. Dig Dis Sci 1997;42:1-5. (Pubitemid 27059914)
29. Winne D, Gorig H. Appearance of 14C-polyethylene glycol 4000 in intestinal venous blood: influence of osmolarity and laxatives, effect on net water flux determination. Naunyn Schmiedebergs Arch Pharmacol 1982;321:149-156. (Pubitemid 13238885)
30. Ameno H, Tani T, Hanasawa K, Kodama M. New method for the detection of bacterial translocation using intestinal permeability with polyethylene glycol 4000. Eur Surg Res 2000;32:23-29. (Pubitemid 30145364)
31. Loret S, Nollevaux G, Remacle R, et al. Analysis of PEG 400 and 4000 in urine for gut permeability assessment using solid phase extraction and gel permeation chromatography with refractometric detection. J Chromatogr B Analyt Technol Biomed Life Sci 2004;805:195-202.
32. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995;108:1566-1581.
33. Chadwick VS, Chen W, Shu D, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002;122:1778-1783. (Pubitemid 34651421)
34. Jacob C, Yang PC, Darmoul D, et al. Mast cell tryptase controls paracellular permeability of the intestine: role of protease-activated receptor 2 and beta-arrestins. J Biol Chem 2005;280:31936-31948. (Pubitemid 41291944)